Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy

References

• Handayani D. Corona Virus Disease 2019. J Respirologi Indones. 2020;40(2). doi:10.36497/jri.v40i2.101
   Google Scholar
• Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30(2):209–217. doi:10.1093/ndt/gfu023
   PubMed Web of Science ®Google Scholar
• Napoli PE, Mangoni L, Gentile P, Braghiroli M, Fossarello M. A panel of broad-spectrum antivirals in topical ophthalmic medications from the drug repurposing approach during and after the coronavirus disease 2019 era. J Clin Med. 2020;9(8):2441. doi:10.3390/jcm9082441
   PubMed Web of Science ®Google Scholar
• Budiman A, Nurfadilah N, Muchtaridi M, Sriwidodo S, Aulifa D Lia, Rusdin A. The Impact of Water-Soluble Chitosan on the Inhibition of Crystal Nucleation of Alpha-Mangostin from Supersaturated Solutions. Polymers. 2022;14(20): 4370. doi:10.3390/polym14204370
   PubMed Web of Science ®Google Scholar
• Mahajan K, Rojekar S, Desai D, et al. Layer-by-layer assembled nanostructured lipid carriers for CD-44 receptor–based targeting in HIV-infected macrophages for efficient HIV-1 inhibition. AAPS Pharm Sci Tech. 2021;22(5):171. doi:10.1208/s12249-021-01981-4
   PubMed Web of Science ®Google Scholar
• Fotooh Abadi L, Damiri F, Zehravi M, et al. Novel nanotechnology-based approaches for targeting HIV reservoirs. Polymers. 2022;14(15):3090. doi:10.3390/polym14153090
   PubMed Web of Science ®Google Scholar
• Rojekar S, Abadi LF, Pai R, Mahajan K, Kulkarni S, Vavia PR. Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: an in-vivo proof of concept. Eur J Pharm Sci. 2021;164:105916. doi:10.1016/j.ejps.2021.105916
   PubMed Web of Science ®Google Scholar
• Rojekar S, Pai R, Abadi LF, et al. Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy. Int J Pharm. 2021;607:120986. doi:10.1016/j.ijpharm.2021.120986
   PubMedGoogle Scholar
• Rojekar S, Abadi LF, Pai R, Prajapati MK, Kulkarni S, Vavia PR. Mannose-anchored nano-selenium loaded nanostructured lipid carriers of etravirine for delivery to HIV reservoirs. AAPS Pharm Sci Tech. 2022;23(7):230. doi:10.1208/s12249-022-02377-8
   PubMed Web of Science ®Google Scholar
• Abate C, Carnamucio F, Giuffrè O, Foti C. Metal-based compounds in antiviral therapy. Biomolecules. 2022;12(7):933. doi:10.3390/biom12070933
   PubMed Web of Science ®Google Scholar
• Žigrayová D, Mikušová V, Mikuš P. Advances in antiviral delivery systems and chitosan-based polymeric and nanoparticulate antivirals and antiviral carriers. Viruses. 2023;15(3):647. doi:10.3390/v15030647
   PubMed Web of Science ®Google Scholar
• Delshadi R, Bahrami A, McClements DJ, Moore MD, Williams L. Development of nanoparticle-delivery systems for antiviral agents: a review. J Control Release. 2021;331:30–44. doi:10.1016/j.jconrel.2021.01.017
   PubMed Web of Science ®Google Scholar
• Mazumder S, Dewangan AK, Pavurala N. Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices. Asian J Pharm Sci. 2017;12(6):532–541. doi:10.1016/j.ajps.2017.07.002
   PubMed Web of Science ®Google Scholar
• Wang LY, Yu Y-M, Yu M-C, Li Y-T, Wu Z-Y, Yan C-W. A crystalline solid adduct of sulfathiazole-amantadine: the first dual-drug molecular salt containing both antiviral and antibacterial ingredients. CrystEngComm. 2020;22(22):3804–3813. doi:10.1039/d0ce00368a
   Web of Science ®Google Scholar
• Sorinolu AJ, Mamun MM, Vadarevu H, Vivero-Escoto JL, Vejerano EP, Munir M. Antiviral activity of nano-monocaprin against Phi6 as a surrogate for SARS-CoV-2. Int Microbiol. 2022;0123456789. doi:10.1007/s10123-022-00300-6
   Web of Science ®Google Scholar
• Moradian H, Roch T, Anthofer L, Lendlein A, Gossen M. Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages. Mol Ther Nucleic Acids. 2022;27:854–869. doi:10.1016/j.omtn.2022.01.004
   PubMedGoogle Scholar
• Giongo V, Falanga A, De Melo CPP, et al. Antiviral potential of naphthoquinones derivatives encapsulated within liposomes. Molecules. 2021;26(21):6440. doi:10.3390/molecules26216440
   PubMed Web of Science ®Google Scholar
• Wang LY, Bu FZ, Li YT, Wu ZY, Yan CW. A Sulfathiazole-Amantadine Hydrochloride Cocrystal: the First Codrug Simultaneously Comprising Antiviral and Antibacterial Components. Cryst Growth Des. 2020;20(5):3236–3246. doi:10.1021/acs.cgd.0c00075
   Web of Science ®Google Scholar
• Lefkowitz EJ, Dempsey DM, Hendrickson RC, Orton RJ, Siddell SG, Smith DB. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Res. 2018;46(D1):D708–D717. doi:10.1093/nar/gkx932
   PubMed Web of Science ®Google Scholar
• Morgan GJ. What is a virus species? Radical pluralism in viral taxonomy. Stud Hist Philos Sci Part C Stud Hist Philos Biol Biomed Sci. 2016;59:64–70. doi:10.1016/j.shpsc.2016.02.009
   PubMedGoogle Scholar
• Barr JN, Fearns R. Genetic instability of RNA viruses. In: Genome Stability. Elsevier; 2016:21–35.
   Google Scholar
• Calisher CH. The taxonomy of viruses should include viruses. Arch. Virol. 2016;161(5):1419–1422. doi:10.1007/s00705-016-2779-x
   PubMed Web of Science ®Google Scholar
• Francki RIB, Fauquet CM, Knudson DL, Brown F. Classification and Nomenclature of Viruses: Fifth Report of the International Committee on Taxonomy of Viruses. Virology Division of the International Union of Microbiological Societies. Vol. 2. Springer Science & Business Media; 2012.
   Google Scholar
• Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6(10):4047–4079. doi:10.3390/v6104047
   PubMed Web of Science ®Google Scholar
• West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017;17(6):363–375. doi:10.1038/nri.2017.21
   PubMed Web of Science ®Google Scholar
• Chin Y-W, Kinghorn AD. Structural Characterization, Biological Effects, and Synthetic Studies on Xanthones from Mangosteen (Garcinia mangostana), a Popular Botanical Dietary Supplement. Mini Rev Org Chem. 2008;5(4):355–364. doi:10.2174/157019308786242223
   PubMed Web of Science ®Google Scholar
• Domingo E. Virus as Populations: Composition, Complexity, Dynamics, and Biological Implications. Academic Press; 2015.
   Google Scholar
• McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta. 2008;1782(3):127–150.
   PubMed Web of Science ®Google Scholar
• Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63(6):1129–1136. doi:10.1016/0092-8674(90)90409-8
   PubMed Web of Science ®Google Scholar
• Cazalet C, Rusniok C, Brüggemann H, et al. Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity. Nat Genet. 2004;36(11):1165–1173. doi:10.1038/ng1447
   PubMed Web of Science ®Google Scholar
• Lori F, Lisziewicz J, Smythe J, et al. Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag. Gene Ther. 1994;1(1):27–31.
   PubMed Web of Science ®Google Scholar
• Baba M, Nishimura O, Kanzaki N, et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci. 1999;96(10):5698–5703. doi:10.1073/pnas.96.10.5698
   PubMed Web of Science ®Google Scholar
• Westby M, van der Ryst E. CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection. Antivir Chem Chemother. 2005;16(6):339–354. doi:10.1177/095632020501600601
   PubMedGoogle Scholar
• Leung D, Abbenante G, Fairlie DP. Protease inhibitors: current status and future prospects. J Med Chem. 2000;43(3):305–341. doi:10.1021/jm990412m
   PubMed Web of Science ®Google Scholar
• Nowak DA, Hermsdörfer J, Glasauer S, Philipp J, Meyer L, Mai N. The effects of digital anaesthesia on predictive grip force adjustments during vertical movements of a grasped object. Eur J Neurosci. 2001;14(4):756–762. doi:10.1046/j.0953-816x.2001.01697.x
   PubMed Web of Science ®Google Scholar
• de Béthune M-P. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989–2009). Antiviral Res. 2010;85(1):75–90. doi:10.1016/j.antiviral.2009.09.008
   PubMed Web of Science ®Google Scholar
• Sluis-Cremer N, Arion D, Parniak MA. Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell Mol Life Sci C. 2000;57(10):1408–1422. doi:10.1007/PL00000626
   PubMed Web of Science ®Google Scholar
• Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity. 2016;44(4):739–754. doi:10.1016/j.immuni.2016.04.002
   PubMed Web of Science ®Google Scholar
• Kanneganti T-D. Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol. 2010;10(10):688–698. doi:10.1038/nri2851
   PubMed Web of Science ®Google Scholar
• Van Regenmortel MHV. Applying the species concept to plant viruses. Arch. Virol. 1989;104(1):1–17. doi:10.1007/BF01313804
   PubMed Web of Science ®Google Scholar
• Crow YJ. Type I interferonopathies: Mendelian type I interferon up-regulation. Curr Opin Immunol. 2015;32:7–12. doi:10.1016/j.coi.2014.10.005
   PubMed Web of Science ®Google Scholar
• Weidenmaier C, Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol. 2008;6(4):276–287. doi:10.1038/nrmicro1861
   PubMed Web of Science ®Google Scholar
• Jana B, Chatterjee A, Roy D, et al. Chitosan/benzyloxy-benzaldehyde modified ZnO nano template having optimized and distinct antiviral potency to human cytomegalovirus. Carbohydr Polym. 2022;278(2021):118965. doi:10.1016/j.carbpol.2021.118965
   PubMedGoogle Scholar
• Galante AJ, Yates KA, Romanowski EG, Shanks RMQ, Leu PW. Coal-Derived Functionalized Nano-Graphene Oxide for Bleach Washable, Durable Antiviral Fabric Coatings. ACS Appl Nano Mater. 2022;5(1):718–728. doi:10.1021/acsanm.1c03448
   Web of Science ®Google Scholar
• Alhakamy NA, Ahmed OAA, Ibrahim TS, et al. Evaluation of the antiviral activity of sitagliptin-glatiramer acetate nano-conjugates against sars-cov-2 virus. Pharmaceuticals. 2021;14(3):1–16. doi:10.3390/ph14030178
   Web of Science ®Google Scholar
• Zakaria MY, Abd El-Halim SM, Beshay BY, Zaki I, Abourehab MAS. ‘Poly phenolic phytoceutical loaded nano-bilosomes for enhanced caco-2 cell permeability and SARS-CoV 2 antiviral activity’: in-vitro and insilico studies. Drug Deliv. 2023;30(1). doi:10.1080/10717544.2022.2162157
   PubMed Web of Science ®Google Scholar
• Dolatyari M, Rostami A. Strong anti-viral nano biocide based on Ag/ZnO modified by amodiaquine as an antibacterial and antiviral composite. Sci Rep. 2022;12(1):1–11. doi:10.1038/s41598-022-24540-8
   PubMed Web of Science ®Google Scholar
• Ullah F, et al. Synthesis and surface modification of chitosan built nanohydrogel with antiviral and antimicrobial agent for controlled drug delivery. Biointerface Res Appl Chem. 2019;9(6):4439–4445. doi:10.33263/BRIAC96.439445
   Web of Science ®Google Scholar
• Bhattacharya I, Yadavalli T, Wu D, Shukla D. Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1. Viruses. 2022;14(4):1–13. doi:10.3390/v14040799
   Web of Science ®Google Scholar
• Zakaria MY, Fayad E, Althobaiti F, Zaki I, Abu Almaaty AH. Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice. Drug Deliv. 2021;28(1):1150–1165. doi:10.1080/10717544.2021.1934190
   PubMed Web of Science ®Google Scholar
• Wang LY, Zhao M-Y, Bu F-Z, et al. Cocrystallization of Amantadine Hydrochloride with Resveratrol: the First Drug-Nutraceutical Cocrystal Displaying Synergistic Antiviral Activity. Cryst Growth Des. 2021;21(5):2763–2776. doi:10.1021/acs.cgd.0c01673
   Web of Science ®Google Scholar
• Yadav D, Savjani J, Savjani K, Kumar A, Patel S. Pharmaceutical Co-crystal of Antiviral Agent Efavirenz with Nicotinamide for the Enhancement of Solubility, Physicochemical Stability, and Oral Bioavailability. AAPS Pharm Sci Tech. 2022;24(1):7. doi:10.1208/s12249-022-02467-7
   PubMed Web of Science ®Google Scholar
• Damian F, Blaton N, Kinget R, Van Den Mooter G. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire® 44/14 and PVP K30. Int J Pharm. 2002;244(1–2):87–98. doi:10.1016/S0378-5173(02)00316-2
   PubMed Web of Science ®Google Scholar
• Damian F, Blaton N, Naesens L, et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci. 2000;10(4):311–322. doi:10.1016/S0928-0987(00)00084-1
   PubMed Web of Science ®Google Scholar
• Wang L-Y, Bu F-Z, Yu Y-M, et al. A novel crystalline molecular salt of sulfamethoxazole and amantadine hybridizing antiviral-antibacterial dual drugs with optimal in vitro/vivo pharmaceutical properties. Eur J Pharm Sci. 2021;163:105883. doi:10.1016/j.ejps.2021.105883
   PubMed Web of Science ®Google Scholar
• Yoon J, Kim J, Lee J, et al. Fabrication of antiviral nanofibers containing various Cu salts and ZnO nanorods by electrospinning. J Ind Eng Chem. 2022;116:572–580. doi:10.1016/j.jiec.2022.09.045
   Web of Science ®Google Scholar
• Chen S, Gao Y, Lou X, et al. Overcoming Bioavailability Challenges of Dasabuvir and Enabling a Triple-Combination Direct-Acting Antiviral HCV Regimen through a Salt of Very Weak Acid for Oral Delivery. Mol Pharm. 2022;19(7):2367–2379. doi:10.1021/acs.molpharmaceut.2c00161
   PubMedGoogle Scholar
• Vorozhtsov NO, Yarovaya OI, Roznyatovskii VA, et al. Synthesis and antiviral activity of novel 3-substituted pyrazolinium salts. Chem Heterocycl Compd. 2021;57(4):432–441. doi:10.1007/s10593-021-02921-7
   Web of Science ®Google Scholar
• Martínez-Gualda B, Sun L, Martí-Marí O, et al. Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum. Antiviral Res. 2019;168:210–214. doi:10.1016/j.antiviral.2019.06.006
   PubMed Web of Science ®Google Scholar
• Chuchkov K, Chayrov R, Hinkov A, Todorov D, Shishkova K, Stankova IG. Modifications on the heterocyclic base of ganciclovir, penciclovir, Acyclovir - syntheses and antiviral properties. Nucleosides Nucleotides Nucleic Acids. 2020;39(7):979–990. doi:10.1080/15257770.2020.1725043
   PubMed Web of Science ®Google Scholar
• Whittle E, Martín-Illana A, Cazorla-Luna R, et al. Silane modification of mesoporous materials for the optimization of antiviral drug adsorption and release capabilities in vaginal media. Pharmaceutics. 2021;13(9):1416. doi:10.3390/pharmaceutics13091416
   PubMed Web of Science ®Google Scholar
• Qiao Z, Wei N, Jin L, et al. The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus. Bioorg Chem. 2021;117:105455. doi:10.1016/j.bioorg.2021.105455
   PubMed Web of Science ®Google Scholar
• Spagnoli G, Pouyanfard S, Cavazzini D, et al. Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles. Sci Rep. 2017;7(1):1–13. doi:10.1038/s41598-017-18177-1
   PubMedGoogle Scholar
• Smith BJ, McKimm-Breshkin JL, McDonald M, Fernley RT, Varghese JN, Colman PM. Structural studies of the resistance of influenza virus neuramindase to inhibitors. J Med Chem. 2002;45(11):2207–2212. doi:10.1021/jm010528u
   PubMed Web of Science ®Google Scholar
• Gubareva LV. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 2004;103(1–2):199–203. doi:10.1016/j.virusres.2004.02.034
   PubMed Web of Science ®Google Scholar
• Bantia S, Arnold CS, Parker CD, Upshaw R, Chand P. Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res. 2006;69(1):39–45. doi:10.1016/j.antiviral.2005.10.002
   PubMed Web of Science ®Google Scholar
• Ishizuka H, Yoshiba S, Okabe H, Yoshihara K. Clinical pharmacokinetics of laninamivir, a novel long‐acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS‐8958, in healthy male volunteers. J Clin Pharmacol. 2010;50(11):1319–1329. doi:10.1177/0091270009356297
   PubMed Web of Science ®Google Scholar
• Grabrucker AM, et al. Nanoparticles as blood–brain barrier permeable CNS targeted drug delivery systems. In: The Blood Brain Barrier (BBB). Springer; 2013:71–89.
   Google Scholar
• Nel A, Ruoslahti E, Meng H. New insights into ‘permeability’ as in the enhanced permeability and retention effect of cancer nanotherapeutics Acs Nano. Vol. 11(10):ACS Publications:9567–9569. 2017
   Google Scholar
• Meijer DKF, Jansen RW, Molema G. Drug targeting systems for antiviral agents: options and limitations. Antiviral Res. 1992;18(3–4):215–258. doi:10.1016/0166-3542(92)90058-D
   PubMed Web of Science ®Google Scholar
• Sinha B, Müller RH, Möschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm. 2013;453(1):126–141. doi:10.1016/j.ijpharm.2013.01.019
   PubMed Web of Science ®Google Scholar
• Alzaid A, et al. Saudi Parents’ Knowledge, Attitudes, and Practices Regarding Antibiotic use for Upper Respiratory Tract Infections in Children. Int J Pharm Res Allied Sci. 2020;9(1):56.
   Web of Science ®Google Scholar
• Sankarganesh M, Adwin Jose P, Dhaveethu Raja J, et al. New pyrimidine based ligand capped gold and platinum nano particles: synthesis, characterization, antimicrobial, antioxidant, DNA interaction and in vitro anticancer activities. J Photochem Photobiol B: Biol. 2017;176:44–53. doi:10.1016/j.jphotobiol.2017.09.013
   PubMed Web of Science ®Google Scholar
• Chen Z-L, Huang M, Wang X-R, et al. Transferrin-modified liposome promotes α-mangostin to penetrate the blood–brain barrier. Nanomedicine Nanotechnology, Biol Med. 2016;12(2):421–430. doi:10.1016/j.nano.2015.10.021
   PubMed Web of Science ®Google Scholar
• Drozd KV, Manin AN, Voronin AP, Boycov DE, Churakov AV, Perlovich GL. A combined experimental and theoretical study of miconazole salts and cocrystals: crystal structures, DFT computations, formation thermodynamics and solubility improvement. Phys Chem Chem Phys. 2021;23(21):12456–12470. doi:10.1039/D1CP00956G
   PubMed Web of Science ®Google Scholar
• Nechipadappu SK, Reddy IR, Tarafder K, Trivedi DR. Salt/cocrystal of anti-fibrinolytic hemostatic drug tranexamic acid: structural, DFT, and stability study of salt/cocrystal with GRAS molecules. Cryst Growth Des. 2018;19(1):347–361. doi:10.1021/acs.cgd.8b01451
   Web of Science ®Google Scholar
• Dengale SJ, Grohganz H, Rades T, Löbmann K. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 2016;100(2016):116–125. doi:10.1016/j.addr.2015.12.009
   PubMedGoogle Scholar
• Buldurun K, Turan N, Bursal E, et al. Synthesis, spectroscopic properties, crystal structures, antioxidant activities and enzyme inhibition determination of Co(II) and Fe(II) complexes of Schiff base. Res Chem Intermed. 2020;46(1):283–297. doi:10.1007/s11164-019-03949-3
   Web of Science ®Google Scholar
• Venkateswarlu K, Kumar MP, Rambabu A, et al. Crystal structure, DNA binding, cleavage, antioxidant and antibacterial studies of Cu(II), Ni(II) and Co(III) complexes with 2-((furan-2-yl)methylimino)methyl)-6-ethoxyphenol Schiff base. J Mol Struct. 2018;1160(Ii):198–207. doi:10.1016/j.molstruc.2018.02.004
   Google Scholar
• Li S-D, Li P-W, Yang Z-M, et al. Synthesis and characterization of chitosan quaternary ammonium salt and its application as drug carrier for ribavirin. Drug Deliv. 2014;21(7):548–552. doi:10.3109/10717544.2013.853708
   PubMed Web of Science ®Google Scholar
• Moser D, Duan Y, Wang F, Ma Y, O’Neill MJ, Cornella J. Selective functionalization of aminoheterocycles by a pyrylium salt. Angew Chem Int Ed. 2018;57(34):11035–11039. doi:10.1002/anie.201806271
   PubMed Web of Science ®Google Scholar
• Alatas F. Perbaikan Kelarutan Albendazol Melalui Pembentukan Kristal Multikomponen dengan Asam Malat. J Farm Galen. 2020;6(1):114–123.
   Google Scholar
• Hamill RJ, Sobel J, El‐Sadr W, et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis. 2010;51(2):225–232. doi:10.1086/653606
   PubMed Web of Science ®Google Scholar
• Budiman A, Citraloka Z Ganesya, Muchtaridi M, Sriwidodo S, Aulifa D Lia and Rusdin A. (2022). Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs—The Case of Alpha-Mangostin. Pharmaceutics, 14(11), 2386 10.3390/pharmaceutics14112386
   PubMed Web of Science ®Google Scholar
• Begines B, Ortiz T, Pérez-Aranda M, et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials. 2020;10(7):1403. doi:10.3390/nano10071403
   Web of Science ®Google Scholar
• Yao Y, Zhou Y, Liu L, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193. doi:10.3389/fmolb.2020.00193
   PubMed Web of Science ®Google Scholar
• Yoo J, Park C, Yi G, Lee D, Koo H. Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers. 2019;11(5):640. doi:10.3390/cancers11050640
   PubMed Web of Science ®Google Scholar
• Sur S, Rathore A, Dave V, Reddy KR, Chouhan RS, Sadhu V. Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano-Struct Nano-Objects. 2019;20:100397. doi:10.1016/j.nanoso.2019.100397
   Google Scholar
• Filipczak N, Pan J, Yalamarty SSK, Torchilin VP. Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020;156:4–22. doi:10.1016/j.addr.2020.06.022
   PubMed Web of Science ®Google Scholar
• Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851. doi:10.1016/j.addr.2021.113851
   PubMed Web of Science ®Google Scholar
• Maja L, Željko K, Mateja P. Sustainable technologies for liposome preparation. J Supercritical Fluids. 2020;165:104984. doi:10.1016/j.supflu.2020.104984
   Web of Science ®Google Scholar
• Huang Y, Kuminek G, Roy L, Cavanagh KL, Yin Q, Rodríguez-Hornedo N. Cocrystal solubility advantage diagrams as a means to control dissolution, supersaturation, and precipitation. Mol Pharm. 2019;16(9):3887–3895. doi:10.1021/acs.molpharmaceut.9b00501
   PubMedGoogle Scholar
• Cavanagh KL, Kuminek G, Rodríguez-Hornedo N. Cocrystal solubility advantage and dose/solubility ratio diagrams: a mechanistic approach to selecting additives and controlling dissolution–supersaturation–precipitation behavior. Mol Pharm. 2020;17(11):4286–4301. doi:10.1021/acs.molpharmaceut.0c00713
   PubMedGoogle Scholar
• Zhang Y-X, Wang L-Y, Dai J-K, et al. The comparative study of cocrystal/salt in simultaneously improving solubility and permeability of Acetazolamide. J Mol Struct. 2019;1184:225–232. doi:10.1016/j.molstruc.2019.01.090
   Web of Science ®Google Scholar